Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative study.

ABSTRACT:

Objective

The use of adjuvant endocrine therapy (AET) after primary treatment of hormone receptor-positive breast cancer reduces the risk of recurrence and mortality. However, non-adherence is still common. Limited consideration has been given to how users deal with AET and the role of pharmaceutical care. Therefore, this study aims to obtain insight into the needs and wishes of women using AET regarding pharmaceutical care and eHealth.

Methods

This is a qualitative explorative study comprising semi-structured interviews (n = 16) and a focus group (n = 5) among women who use or used AET after primary early-stage breast cancer (EBC) treatment using a thematic analysis approach.

Results

Three themes emerged from the interviews and focus group: (1) experiences with AET u

SUBMITTER: En-Nasery-de Heer S 

PROVIDER: S-EPMC9786726 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature